13therapeutics

Biotechnology ResearchOregon, United States2-10 Employees

13therapeutics is a small biotechnology research company focused on identifying and characterizing anti-inflammatory peptide therapeutics for unmet medical needs. The organization relies on a platform that discovers and enhances peptides derived from naturally occurring pathogens such as bacteria, viruses, and fungi that influence the human immune system. This work has produced a portfolio of peptide candidates showing immune-regulatory activity across different mechanisms of action.

These peptides have the potential to treat both acute and chronic inflammatory diseases and offer various delivery possibilities while demonstrating serum stability. Its target conditions include acute inflammatory scenarios such as Acute Otitis Media, systemic inflammation, meningitis, traumatic brain injury, uveitis, and ischemia, while chronic models being explored include lupus, rheumatoid arthritis, multiple sclerosis, atherosclerosis, Crohn's disease, and psoriasis. The company is based in Portland, Oregon, and pursues development across several disease areas through an evolution-based approach.

Sign up for free to view info

Email Format Employee directory